Lancashire and South Cumbria
Formulary
Formulary
12 Ear, nose and oropharynx
|
12-02-03 Nasal Staphylococci
| Chlorhexidine with neomycin Naseptin® |
|
Formulary
|
Nasal cream Chlorhexidine Hydrochloride 0.1%, Neomycin Suphate 0.5% |
 MHRA: Medical Device Alert Naseptin Nasal Cream: Caution advised when prescribing and dispensing due to reformulation to remove allergen |
|
Links
- LSCMMG: Inflammatory Bowel Disease: High Cost Drugs Commissioning Pathway
- LSCMMG: Primary Care Constipation Guidelines
- MHRA alert: Anaphylaxis risk with chlorhexidine
- MHRA: Antiepileptic drugs in pregnancy: updated advice following comprehensive safety review
- MHRA: Medical Device Alert
- Naseptin Nasal Cream: Caution advised when prescribing and dispensing due to reformulation to remove allergen
- NICE CG147: Diverticular disease: diagnosis and management
- NICE CG184 Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management
- NICE CG61: Irritable bowel syndrome in adults: diagnosis and management
- NICE NG1: Gastro-oesophageal reflux disease: recognition, diagnosis and management in children and young people